Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Anemia

  Free Subscription


Articles published in Int J Hematol

Retrieve available abstracts of 101 articles:
HTML format



Single Articles


    April 2021
  1. CHEN S, Guo Z, Ye Y, Yang S, et al
    Compound heterozygosity for two novel mutations of the SEC23B gene in congenital dyserythropoietic anemia type II.
    Int J Hematol. 2021 Apr 29. pii: 10.1007/s12185-021-03155.
    PubMed     Abstract available


  2. NARUKAWA K, Masuda A, Takahashi T
    Marked erythropoietin-induced dysplastic erythropoiesis in a patient with myelodysplastic syndrome.
    Int J Hematol. 2021 Apr 17. pii: 10.1007/s12185-021-03147.
    PubMed    


    March 2021
  3. KOMATSU N, Arita K, Mitsui H, Nemoto T, et al
    Efficacy and safety of ferric citrate hydrate compared with sodium ferrous citrate in Japanese patients with iron deficiency anemia: a randomized, double-blind, phase 3 non-inferiority study.
    Int J Hematol. 2021 Mar 15. pii: 10.1007/s12185-021-03123.
    PubMed     Abstract available


    January 2021
  4. ROSTAMI T, Monzavi SM, Poustchi H, Khoshdel AR, et al
    Analysis of determinant factors of liver fibrosis progression in ex-thalassemic patients.
    Int J Hematol. 2021;113:145-157.
    PubMed     Abstract available


  5. NAKAMURA Y, Takenaka K, Yamazaki H, Onishi Y, et al
    Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with paroxysmal nocturnal hemoglobinuria.
    Int J Hematol. 2021;113:122-127.
    PubMed     Abstract available


    December 2020
  6. SUN Y, Liu C, Jiao T, Xie N, et al
    Decreased LAG3 expression on T effector cells and regulatory T cells in SAA.
    Int J Hematol. 2020;112:757-763.
    PubMed     Abstract available


    October 2020
  7. NAKAYA A, Kohara T, Shibayama H, Onda Y, et al
    Retrospective multi-center study of Adolescent and Young Adult (AYA) Multiple Myeloma in Kansai Myeloma Forum registry.
    Int J Hematol. 2020;112:435-438.
    PubMed     Abstract available


  8. ISHIYAMA K, Nakao S, Usuki K, Yonemura Y, et al
    Results from multinational phase 3 studies of ravulizumab (ALXN1210) versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria: subgroup analysis of Japanese patients.
    Int J Hematol. 2020;112:466-476.
    PubMed     Abstract available


    September 2020
  9. YABE M, Morio T, Tabuchi K, Tomizawa D, et al
    Long-term outcome in patients with Fanconi anemia who received hematopoietic stem cell transplantation: a retrospective nationwide analysis.
    Int J Hematol. 2020 Sep 19. pii: 10.1007/s12185-020-02991.
    PubMed     Abstract available


  10. ISE M, Iizuka H, Kamoda Y, Hirao M, et al
    Romiplostim is effective for eltrombopag-refractory aplastic anemia: results of a retrospective study.
    Int J Hematol. 2020 Sep 2. pii: 10.1007/s12185-020-02971.
    PubMed     Abstract available


  11. KAMESAKI T, Nishimura JI, Wada H, Yu E, et al
    Demographic characteristics, thromboembolism risk, and treatment patterns for patients with cold agglutinin disease in Japan.
    Int J Hematol. 2020;112:307-315.
    PubMed     Abstract available


    August 2020
  12. AKRAM T, Fatima A, Klar J, Hoeber J, et al
    Aberrant splicing due to a novel RPS7 variant causes Diamond-Blackfan Anemia associated with spontaneous remission and meningocele.
    Int J Hematol. 2020 Aug 9. pii: 10.1007/s12185-020-02950.
    PubMed     Abstract available


  13. YE L, Zhang F, Kojima S
    Current insights into the treatments of severe aplastic anemia in China.
    Int J Hematol. 2020 Aug 3. pii: 10.1007/s12185-020-02955.
    PubMed     Abstract available


    June 2020
  14. HONG J, Ni J, Ruan M, Yang M, et al
    LMP1-specific cytotoxic T cells for the treatment of EBV-related post-transplantation lymphoproliferative disorders.
    Int J Hematol. 2020;111:851-857.
    PubMed     Abstract available


    May 2020
  15. KAGEYAMA Y, Katayama N
    Ontogeny of human B1 cells.
    Int J Hematol. 2020;111:628-633.
    PubMed     Abstract available


  16. SAKURAI M, Takemoto H, Mori T, Okamoto S, et al
    In vivo expansion of functional human hematopoietic stem progenitor cells by butyzamide.
    Int J Hematol. 2020;111:739-741.
    PubMed    


    April 2020
  17. EDAHIRO Y, Yasuda H, Ando K, Komatsu N, et al
    Self-limiting pregnancy-associated pure red cell aplasia developing in two consecutive pregnancies: case report and literature review.
    Int J Hematol. 2020;111:579-584.
    PubMed     Abstract available


    March 2020
  18. CHE YAACOB NS, Islam MA, Alsaleh H, Ibrahim IK, et al
    Alpha-hemoglobin-stabilizing protein (AHSP): a modulatory factor in beta-thalassemia.
    Int J Hematol. 2020;111:352-359.
    PubMed     Abstract available


    February 2020
  19. NOPPARATANA C, Nopparatana C, Saechan V, Karnchanaopas S, et al
    Prenatal diagnosis of alpha- and beta-thalassemias in southern Thailand.
    Int J Hematol. 2020;111:284-292.
    PubMed     Abstract available


    January 2020
  20. KITAO A, Kawamoto S, Kurata K, Hayakawa I, et al
    Band 3 ectopic expression in colorectal cancer induces an increase in erythrocyte membrane-bound IgG and may cause immune-related anemia.
    Int J Hematol. 2020 Jan 30. pii: 10.1007/s12185-020-02831.
    PubMed     Abstract available


  21. JIANG J, Cai Y, Wan L, Yang J, et al
    Cord blood infusion-accelerated hematopoietic recovery after combined immunosuppressive therapy with fludarabine and rabbit ATG in severe aplastic anemia.
    Int J Hematol. 2020 Jan 3. pii: 10.1007/s12185-019-02807.
    PubMed     Abstract available


    November 2019
  22. YASUDA H, Tsutsui M, Ando J, Inano T, et al
    Vitamin B6 deficiency is prevalent in primary and secondary myelofibrosis patients.
    Int J Hematol. 2019;110:543-549.
    PubMed     Abstract available


    October 2019
  23. SAKURAI M, Jang JH, Chou WC, Kim JS, et al
    Comparative study on baseline clinical characteristics of Asian versus non-Asian patients with paroxysmal nocturnal hemoglobinuria.
    Int J Hematol. 2019;110:411-418.
    PubMed     Abstract available


  24. MANKHEMTHONG K, Phusua A, Suanta S, Srisittipoj P, et al
    Molecular characteristics of thalassemia and hemoglobin variants in prenatal diagnosis program in northern Thailand.
    Int J Hematol. 2019;110:474-481.
    PubMed     Abstract available


    August 2019
  25. KEDAR PS, Harigae H, Ito E, Muramatsu H, et al
    Study of pathophysiology and molecular characterization of congenital anemia in India using targeted next-generation sequencing approach.
    Int J Hematol. 2019 Aug 10. pii: 10.1007/s12185-019-02716.
    PubMed     Abstract available


  26. JANG W, Kim J, Chae H, Kim M, et al
    Hereditary spherocytosis caused by copy number variation in SPTB gene identified through targeted next-generation sequencing.
    Int J Hematol. 2019;110:250-254.
    PubMed     Abstract available


    June 2019
  27. YAMAZAKI H, Ohta K, Iida H, Imada K, et al
    Hematologic recovery induced by eltrombopag in Japanese patients with aplastic anemia refractory or intolerant to immunosuppressive therapy.
    Int J Hematol. 2019 Jun 10. pii: 10.1007/s12185-019-02683.
    PubMed     Abstract available


    May 2019
  28. KAWAKAMI T, Sekiguchi N, Kobayashi J, Yamane T, et al
    STAT3 mutations in natural killer cells are associated with cytopenia in patients with chronic lymphoproliferative disorder of natural killer cells.
    Int J Hematol. 2019;109:563-571.
    PubMed     Abstract available


    April 2019
  29. MORI T, Onishi Y, Ozawa Y, Kato C, et al
    Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with hepatitis-associated aplastic anemia.
    Int J Hematol. 2019 Apr 8. pii: 10.1007/s12185-019-02644.
    PubMed     Abstract available


    March 2019
  30. LI F, Li W, Qiao X, Xie X, et al
    Clinical features of dyskeratosis congenita in mainland China: case reports and literature review.
    Int J Hematol. 2019;109:328-335.
    PubMed     Abstract available


    January 2019
  31. SAKURAI M, Kikuchi T, Karigane D, Kasahara H, et al
    Renal dysfunction and anemia associated with long-term imatinib treatment in patients with chronic myelogenous leukemia.
    Int J Hematol. 2019 Jan 24. pii: 10.1007/s12185-019-02596.
    PubMed     Abstract available


  32. SHAIKH H, Faisal MS, Mewawalla P
    Vitamin C deficiency: rare cause of severe anemia with hemolysis.
    Int J Hematol. 2019 Jan 22. pii: 10.1007/s12185-018-02575.
    PubMed     Abstract available


  33. KIM EA, Lim YT, Hah JO, Sohn YB, et al
    Correction to: Neuronopathic Gaucher disease presenting with microcytic hypochromic anemia.
    Int J Hematol. 2019 Jan 10. pii: 10.1007/s12185-018-02590.
    PubMed     Abstract available


  34. SASAKI N, Shimura K, Yoshida M, Uoshima N, et al
    Immunosuppressive therapy with rabbit antithymocyte globulin therapy for acquired aplastic anemia: a multi-institutional retrospective study in Japanese adult patients.
    Int J Hematol. 2019 Jan 9. pii: 10.1007/s12185-018-02583.
    PubMed     Abstract available


    December 2018
  35. AKABAYASHI A, Nakazawa E, Jecker NS
    The world's first clinical trial for an aplastic anemia patient with thrombocytopenia administering platelets generated from autologous iPS cells.
    Int J Hematol. 2018 Dec 7. pii: 10.1007/s12185-018-02565.
    PubMed    


  36. RECASENS V, Montanes A, Bustamante E
    Lead poisoning as final diagnosis in a study of normocytic anemia.
    Int J Hematol. 2018 Dec 6. pii: 10.1007/s12185-018-02570.
    PubMed    


    November 2018
  37. KIM EA, Lim YT, Hah JO, Sohn YB, et al
    Neuronopathic Gaucher disease presenting with microcytic hypochromic anemia.
    Int J Hematol. 2018 Nov 19. pii: 10.1007/s12185-018-2559.
    PubMed     Abstract available


  38. KONISHI T, Doki N, Takaki Y, Igarashi A, et al
    Presacral extramedullary hematopoiesis under treatment with an erythropoietin-stimulating agent for myelodysplasia.
    Int J Hematol. 2018 Nov 1. pii: 10.1007/s12185-018-2554.
    PubMed    


    October 2018
  39. INABA T, Ohama A
    Prominent increase of Pappenheimer body-containing erythrocytes in a patient with hypoplastic spleen (IJHM-D-18-00279R2).
    Int J Hematol. 2018;108:351-352.
    PubMed    


  40. NITTAYABOON K, Nopparatana C
    Molecular characterization of Hb H disease in southern Thailand.
    Int J Hematol. 2018;108:384-389.
    PubMed     Abstract available


    September 2018
  41. IKUTA K, Ito H, Takahashi K, Masaki S, et al
    Safety and efficacy of intravenous ferric carboxymaltose in Japanese patients with iron-deficiency anemia caused by digestive diseases: an open-label, single-arm study.
    Int J Hematol. 2018 Sep 7. pii: 10.1007/s12185-018-2529.
    PubMed     Abstract available


    August 2018
  42. ARAKI R, Nishimura R, Kuroda R, Fujiki T, et al
    A characteristic flow cytometric pattern with broad forward scatter and narrowed side scatter helps diagnose immune thrombocytopenia (ITP).
    Int J Hematol. 2018;108:151-160.
    PubMed     Abstract available


  43. WU X, Wang S, Lu X, Shen W, et al
    Response to cyclosporine A and corticosteroids in adult patients with acquired pure red cell aplasia: serial experience at a single center.
    Int J Hematol. 2018;108:123-129.
    PubMed     Abstract available


    July 2018
  44. IKUTA K, Hanashi H, Hirai K, Ota Y, et al
    Comparison of efficacy and safety between intravenous ferric carboxymaltose and saccharated ferric oxide in Japanese patients with iron-deficiency anemia due to hypermenorrhea: a multi-center, randomized, open-label noninferiority study.
    Int J Hematol. 2018 Jul 23. pii: 10.1007/s12185-018-2501.
    PubMed     Abstract available


  45. SONODA M, Ishimura M, Ichimiya Y, Terashi E, et al
    Correction to: Atypical erythroblastosis in a patient with Diamond-Blackfan anemia who developed del(20q) myelodysplasia.
    Int J Hematol. 2018 Jul 2. pii: 10.1007/s12185-018-2493.
    PubMed     Abstract available


  46. ASADOV C, Alimirzoeva Z, Mammadova T, Aliyeva G, et al
    beta-Thalassemia intermedia: a comprehensive overview and novel approaches.
    Int J Hematol. 2018;108:5-21.
    PubMed     Abstract available


    June 2018
  47. HAMADA M, Doisaki S, Okuno Y, Muramatsu H, et al
    Whole-exome analysis to detect congenital hemolytic anemia mimicking congenital dyserythropoietic anemia.
    Int J Hematol. 2018 Jun 23. pii: 10.1007/s12185-018-2482.
    PubMed     Abstract available


  48. UEDA Y, Obara N, Yonemura Y, Noji H, et al
    Effects of eculizumab treatment on quality of life in patients with paroxysmal nocturnal hemoglobinuria in Japan.
    Int J Hematol. 2018;107:656-665.
    PubMed     Abstract available


    March 2018
  49. KHAMPHIKHAM P, Sripichai O, Munkongdee T, Fucharoen S, et al
    Genetic variation of Kruppel-like factor 1 (KLF1) and fetal hemoglobin (HbF) levels in beta(0)-thalassemia/HbE disease.
    Int J Hematol. 2018;107:297-310.
    PubMed     Abstract available


    February 2018
  50. XING L, Xu W, Qu Y, Zhao M, et al
    miR-150 regulates B lymphocyte in autoimmune hemolytic anemia/Evans syndrome by c-Myb.
    Int J Hematol. 2018 Feb 27. pii: 10.1007/s12185-018-2429.
    PubMed     Abstract available


  51. SONODA M, Ishimura M, Ichimiya Y, Terashi E, et al
    Atypical erythroblastosis in a patient with Diamond-Blackfan anemia who developed del(20q) myelodysplasia.
    Int J Hematol. 2018 Feb 23. pii: 10.1007/s12185-018-2424.
    PubMed     Abstract available


  52. RAB MAE, Meerveld-Eggink A, van Velzen-Blad H, van Loon D, et al
    Persistent changes in circulating white blood cell populations after splenectomy.
    Int J Hematol. 2018;107:157-165.
    PubMed     Abstract available


  53. KARNER KH, Inamdar KV
    Plasma cell myeloma mimicking classical Hodgkin lymphoma in the bone marrow.
    Int J Hematol. 2018;107:127-128.
    PubMed    


    January 2018
  54. IKUTA K, Shimura A, Terauchi M, Yoshii K, et al
    Pharmacokinetics, pharmacodynamics, safety, and tolerability of intravenous ferric carboxymaltose: a dose-escalation study in Japanese volunteers with iron-deficiency anemia.
    Int J Hematol. 2018 Jan 22. pii: 10.1007/s12185-018-2400.
    PubMed     Abstract available


  55. GIRELLI D, Ugolini S, Busti F, Marchi G, et al
    Modern iron replacement therapy: clinical and pathophysiological insights.
    Int J Hematol. 2018;107:16-30.
    PubMed     Abstract available


  56. HARIGAE H
    Iron metabolism and related diseases: an overview.
    Int J Hematol. 2018;107:5-6.
    PubMed    


    December 2017
  57. CHAROENKWAN P, Sirichotiyakul S, Phusua A, Suanta S, et al
    High-resolution melting analysis for prenatal diagnosis of beta-thalassemia in northern Thailand.
    Int J Hematol. 2017;106:757-764.
    PubMed     Abstract available


  58. ALGIRAIGRI AH, Kassam A
    Hydroxyurea for hemoglobin E/beta-thalassemia: a systematic review and meta-analysis.
    Int J Hematol. 2017;106:748-756.
    PubMed     Abstract available


    November 2017
  59. FURUYAMA K, Kaneko K
    Iron metabolism in erythroid cells and patients with congenital sideroblastic anemia.
    Int J Hematol. 2017 Nov 14. doi: 10.1007/s12185-017-2368.
    PubMed     Abstract available


  60. SRINOUN K, Nopparatana C, Wongchanchailert M, Fucharoen S, et al
    MiR-155 enhances phagocytic activity of beta-thalassemia/HbE monocytes via targeting of BACH1.
    Int J Hematol. 2017;106:638-647.
    PubMed     Abstract available


  61. KADDAH NA, Saied DA, Alwakeel HA, Hashem RH, et al
    Plasma chitotriosidase and carotid intima-media thickness in children with sickle cell disease.
    Int J Hematol. 2017;106:648-654.
    PubMed     Abstract available


  62. OHKAWARA H, Furukawa M, Ikeda K, Shichishima-Nakamura A, et al
    Steroid-resistant autoimmune myelofibrosis in a patient with autoimmune hepatitis and Evans syndrome complicated with increased expression of TGF-beta in the bone marrow: a case report.
    Int J Hematol. 2017;106:718-724.
    PubMed     Abstract available


    October 2017
  63. IMATAKI O, Uchida S, Yokokura S, Uemura M, et al
    Anemia and hypogammaglobulinemia caused by Menetrier's disease.
    Int J Hematol. 2017 Oct 12. doi: 10.1007/s12185-017-2349.
    PubMed    


    September 2017
  64. CUI Q, Sha P, Chen H, Shen H, et al
    Modified immunosuppressive therapy with porcine antilymphocyte globulin plus delayed cyclosporine A in children with severe aplastic anemia.
    Int J Hematol. 2017 Sep 12. doi: 10.1007/s12185-017-2321.
    PubMed     Abstract available


  65. SATITTHUMMANID S, Uaprasert N, Songmuang SB, Rojnuckarin P, et al
    Depleted nitric oxide and prostaglandin E2 levels are correlated with endothelial dysfunction in beta-thalassemia/HbE patients.
    Int J Hematol. 2017;106:366-374.
    PubMed     Abstract available


    August 2017
  66. XU X, Li L, Xia W, Ding H, et al
    Successful management of a hydropic fetus with severe anemia and thrombocytopenia caused by anti-CD36 antibody.
    Int J Hematol. 2017 Aug 16. doi: 10.1007/s12185-017-2310.
    PubMed     Abstract available


  67. UPANAN S, McKie AT, Latunde-Dada GO, Roytrakul S, et al
    Hepcidin suppression in beta-thalassemia is associated with the down-regulation of atonal homolog 8.
    Int J Hematol. 2017;106:196-205.
    PubMed     Abstract available


    July 2017
  68. KUNIMOTO H, Nakajima H
    Epigenetic dysregulation of hematopoietic stem cells and preleukemic state.
    Int J Hematol. 2017;106:34-44.
    PubMed     Abstract available


  69. TOKI Y, Ikuta K, Kawahara Y, Niizeki N, et al
    Reticulocyte hemoglobin equivalent as a potential marker for diagnosis of iron deficiency.
    Int J Hematol. 2017;106:116-125.
    PubMed     Abstract available


    June 2017
  70. CHOI Y, Jo JC, Jeon HJ, Kim DW, et al
    Trend and treatment patterns of aplastic anemia in Korea, pure red cell aplasia and myelodysplastic syndrome in Korea: a nation-wide analysis.
    Int J Hematol. 2017 Jun 29. doi: 10.1007/s12185-017-2280.
    PubMed     Abstract available


  71. CHEUNG RS, Taniguchi T
    Recent insights into the molecular basis of Fanconi anemia: genes, modifiers, and drivers.
    Int J Hematol. 2017 Jun 19. doi: 10.1007/s12185-017-2283.
    PubMed     Abstract available


  72. LIU C, Zheng M, Zhang T, Fu R, et al
    TRAIL in CD8+ T cells from patients with severe aplastic anemia.
    Int J Hematol. 2017 Jun 19. doi: 10.1007/s12185-017-2279.
    PubMed     Abstract available


  73. ZHAO P, Gao Q, He Q, Tan J, et al
    Prevalence and clinical outcomes of hepatitis B virus infection in patients with aplastic anemia.
    Int J Hematol. 2017 Jun 13. doi: 10.1007/s12185-017-2276.
    PubMed     Abstract available


    May 2017
  74. URESHINO H, Kizuka H, Kusaba K, Sano H, et al
    5q- syndrome-like features as the first manifestation of myelodysplastic syndrome in a patient with an unbalanced whole-arm translocation der(5;19)(p10;q10).
    Int J Hematol. 2017;105:692-696.
    PubMed     Abstract available


    April 2017
  75. ABAZA Y, Yin CC, Bueso-Ramos CE, Wang SA, et al
    Primary autoimmune myelofibrosis: a case report and review of the literature.
    Int J Hematol. 2017;105:536-539.
    PubMed     Abstract available


    March 2017
  76. WU L, Mo W, Zhang Y, Zhou M, et al
    Vascular and perivascular niches, but not the osteoblastic niche, are numerically restored following allogeneic hematopoietic stem cell transplantation in patients with aplastic anemia.
    Int J Hematol. 2017 Mar 16. doi: 10.1007/s12185-017-2217.
    PubMed     Abstract available


  77. IKI S, Ohgi K, Suzuki K
    Eculizumab treatment improved renal hemosiderosis in a patient with paroxysmal nocturnal hemoglobinuria.
    Int J Hematol. 2017;105:231-232.
    PubMed    


  78. ZAHRAN AM, Saad K, Elsayh KI, Alblihed MA, et al
    Characterization of circulating CD4+ CD8+ double positive and CD4- CD8- double negative T-lymphocyte in children with beta-thalassemia major.
    Int J Hematol. 2017;105:265-271.
    PubMed     Abstract available


  79. KOMATSU N, Kirito K, Shimoda K, Ishikawa T, et al
    Assessing the safety and efficacy of ruxolitinib in a multicenter, open-label study in Japanese patients with myelofibrosis.
    Int J Hematol. 2017;105:309-317.
    PubMed     Abstract available


    February 2017
  80. WU L, Xu W, Xu L, Kong Q, et al
    Mitophagy is increased during erythroid differentiation in beta-thalassemia.
    Int J Hematol. 2017;105:162-173.
    PubMed     Abstract available


    January 2017
  81. HAYAKAWA J, Kanda J, Akahoshi Y, Harada N, et al
    Meta-analysis of treatment with rabbit and horse antithymocyte globulin for aplastic anemia.
    Int J Hematol. 2017 Jan 11. doi: 10.1007/s12185-017-2179.
    PubMed     Abstract available


  82. IKEBE T, Takata H, Sasaki H, Miyazaki Y, et al
    Hemophagocytic lymphohistiocytosis following influenza vaccination in a patient with aplastic anemia undergoing allogeneic bone marrow stem cell transplantation.
    Int J Hematol. 2017 Jan 4. doi: 10.1007/s12185-016-2177.
    PubMed    


    December 2016
  83. SEKIGUCHI N, Nishina S, Kawakami T, Sakai H, et al
    Oral cyclophosphamide was effective for Coombs-negative autoimmune hemolytic anemia in CD16+CD56- chronic lymphoproliferative disorder of NK-cells.
    Int J Hematol. 2016 Dec 27. doi: 10.1007/s12185-016-2170.
    PubMed     Abstract available


    November 2016
  84. ICHIMURA T, Yoshida K, Okuno Y, Yujiri T, et al
    Diagnostic challenge of Diamond-Blackfan anemia in mothers and children by whole-exome sequencing.
    Int J Hematol. 2016.
    PubMed     Abstract available


  85. NINOMIYA H, Obara N, Chiba S, Usuki K, et al
    Interim analysis of post-marketing surveillance of eculizumab for paroxysmal nocturnal hemoglobinuria in Japan.
    Int J Hematol. 2016;104:548-558.
    PubMed     Abstract available


    October 2016
  86. GUO Z, Gao HY, Zhang TY, Liu XD, et al
    Analysis of allogeneic hematopoietic stem cell transplantation with high-dose cyclophosphamide-induced immune tolerance for severe aplastic anemia.
    Int J Hematol. 2016.
    PubMed     Abstract available


    August 2016
  87. NAKAO S
    Diagnostic problems in acquired bone marrow failure syndromes.
    Int J Hematol. 2016;104:151-2.
    PubMed    


  88. INOUE S, Kodjebacheva G, Scherrer T, Rice G, et al
    Adherence to hydroxyurea medication by children with sickle cell disease (SCD) using an electronic device: a feasibility study.
    Int J Hematol. 2016;104:200-7.
    PubMed     Abstract available


  89. FALCHI L, Grillo LM, Diuguid-Gerber JL, Eisenberger AB, et al
    Severe mechanical hemolysis in a patient with thalassemia minor who had undergone inappropriate splenectomy.
    Int J Hematol. 2016;104:147-8.
    PubMed    


  90. MIYATA T, Uchida Y, Yoshida Y, Kato H, et al
    No association between dysplasminogenemia with p.Ala620Thr mutation and atypical hemolytic uremic syndrome.
    Int J Hematol. 2016;104:223-7.
    PubMed     Abstract available


  91. MARSH JC, Mufti GJ
    Clinical significance of acquired somatic mutations in aplastic anaemia.
    Int J Hematol. 2016;104:159-67.
    PubMed     Abstract available


    June 2016
  92. YU F, Du Y, Han B
    A comparative analysis of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria between Asia and Europe/America.
    Int J Hematol. 2016;103:649-54.
    PubMed     Abstract available


  93. TANTIWORAWIT A, Charoenkwan P, Hantrakool S, Choeyprasert W, et al
    Iron overload in non-transfusion-dependent thalassemia: association with genotype and clinical risk factors.
    Int J Hematol. 2016;103:643-8.
    PubMed     Abstract available


  94. PIGATTO PD, Ronchi A, Guzzi G
    Iron overload, G6PD deficiency, and lead levels on blood smears.
    Int J Hematol. 2016;103:724.
    PubMed    


  95. MIYASAKA N, Miura O, Kawaguchi T, Arima N, et al
    Pregnancy outcomes of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: a Japanese experience and updated review.
    Int J Hematol. 2016;103:703-12.
    PubMed     Abstract available


    May 2016
  96. DIAMANTIDIS MD, Neokleous N, Agapidou A, Vetsiou E, et al
    Iron chelation therapy of transfusion-dependent beta-thalassemia during pregnancy in the era of novel drugs: is deferasirox toxic?
    Int J Hematol. 2016;103:537-44.
    PubMed     Abstract available


    April 2016
  97. HASEGAWA D
    The current perspective of low-grade myelodysplastic syndrome in children.
    Int J Hematol. 2016;103:360-4.
    PubMed     Abstract available


  98. MANABE A
    Guest Editorial: Inherited bone marrow failure and myelodysplasia in children: how much do we know about pediatric diseases?
    Int J Hematol. 2016;103:359.
    PubMed    


  99. DALLE JH, Peffault de Latour R
    Allogeneic hematopoietic stem cell transplantation for inherited bone marrow failure syndromes.
    Int J Hematol. 2016;103:373-9.
    PubMed     Abstract available


    March 2016
  100. FAN X, Kremer Hovinga JA, Shirotani-Ikejima H, Eura Y, et al
    Genetic variations in complement factors in patients with congenital thrombotic thrombocytopenic purpura with renal insufficiency.
    Int J Hematol. 2016;103:283-91.
    PubMed     Abstract available


    January 2016
  101. ADDO L, Ikuta K, Tanaka H, Toki Y, et al
    The three isoforms of hepcidin in human serum and their processing determined by liquid chromatography-tandem mass spectrometry (LC-tandem MS).
    Int J Hematol. 2016;103:34-43.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: